Selective inhibition of TGF-β-induced epithelial-mesenchymal transition overcomes chemotherapy resistance in high-risk lung squamous cell carcinoma
Abstract Lung squamous cell carcinoma (LUSC) represents a major subtype of lung cancer, and it demonstrates limited treatment options and worse survival. Identifications of a prognostic model and chemoresistance mechanism can be helpful for improving stratification and guiding therapy decisions. The...
Saved in:
Main Authors: | Liangdong Sun, Jue Wang, Huansha Yu, Xinsheng Zhu, Jing Zhang, Junjie Hu, Yilv Yan, Xun Zhang, Yuming Zhu, Gening Jiang, Ming Ding, Peng Zhang, Lele Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-025-07595-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
D-tryptophan triggered epithelial-mesenchymal transition by activating TGF-β signaling pathway
by: Chong Wang, et al.
Published: (2022-09-01) -
UHRF1 promotes epithelial-mesenchymal transition mediating renal fibrosis by activating the TGF-β/SMAD signaling pathway
by: Lijie Yang, et al.
Published: (2025-01-01) -
miR‐130a‐3p regulated TGF‐β1‐induced epithelial‐mesenchymal transition depends on SMAD4 in EC‐1 cells
by: Xiaokang Tian, et al.
Published: (2019-03-01) -
Epithelial mesenchymal transition and cancer stem cell markers in oral epithelial dysplasia and oral squamous cell carcinoma
by: Burcu Tokozlu, et al.
Published: (2024-12-01) -
The Role of TGFβ Signaling in Squamous Cell Cancer: Lessons from Mouse Models
by: Adam B. Glick
Published: (2012-01-01)